Company intelligence / Profile preview
Tioga Pharmaceuticals
San Diego, California, United Statestiogapharma.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Tioga Pharmaceuticals is a clinical-stage pharmaceutical company developing asimadoline, a selective kappa-opioid receptor agonist, for the treatment of pruritus and related conditions. The company has focused on women's health and dermatological indications. Asimadoline has been evaluated in multiple clinical trials for its efficacy in reducing itch associated with various conditions[1][2][6].
- Therapeutic areas
- Women's HealthDermatology
- Modalities
- Small moleculeSynthetic opioid
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Tioga Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tioga Pharmaceuticals.